Your browser doesn't support javascript.
loading
Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891-9895".
Rayson, Daniel; Gandhi, Sonal; Joy, Anil A; Brezden-Masley, Christine; Gelmon, Karen A; Sehdev, Sandeep; Cescon, David; Chia, Stephen.
Afiliación
  • Rayson D; Division of Medical Oncology, Department of Medicine, Queen Elizabeth II Health Sciences Center, Halifax, NS B3H 2Y9, Canada.
  • Gandhi S; Division of Medical Oncology/Hematology, Odette Cancer Centre Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
  • Joy AA; Division of Medical Oncology, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.
  • Brezden-Masley C; Division of Medical Oncology, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
  • Gelmon KA; Division of Medical Oncology, British Columbia Cancer Centre, Vancouver, BC V5Z 4E6, Canada.
  • Sehdev S; Department of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
  • Cescon D; Department of Medical Oncology, University Health Network, Toronto, ON M5G 1Z5, Canada.
  • Chia S; Division of Medical Oncology, British Columbia Cancer Centre, Vancouver, BC V5Z 4E6, Canada.
Curr Oncol ; 30(5): 5050-5053, 2023 05 16.
Article en En | MEDLINE | ID: mdl-37232839
ABSTRACT
We appreciate the opportunity to respond to the comment [...].
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Curr Oncol Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Curr Oncol Año: 2023 Tipo del documento: Article País de afiliación: Canadá